The European Union is increasingly valuing hemp as an important crop for economic and environmental development. The Kanavape case has, in principle, led to legalisation of CBD in the EU, although compliance with the judgement still remains patchy across member states. Meanwhile, there is no EU-wide specific regulatory framework for medicinal cannabis.
This report provides a detailed analysis of the regulatory framework in place in the European Union for cannabis, hemp, CBD and other cannabinoids - intoxicating or not - covering all policy areas.
This report provides a detailed analysis of the regulatory framework in place in the European Union for cannabis, hemp, CBD and other cannabinoids - intoxicating or not - covering all policy areas.
Table of Contents
- Executive summary
- Outlook
- Hemp plant
- Extracts and synthetics
- Finished products containing CBD and extracts
- Import and export requirements
- Minor cannabinoids
- Medical cannabis
- Recreational cannabis
- Relevant laws
- Relevant bodies
Methodology
General Methodology/Sources
- Consumer and market participant (manufacturer/brand) surveys.
- Consolidation of publicly available information.
- Legal tracking through legal database checking and sourcing information from government regulators and other law-making bodies.
- Pricing and product information from online and offline retail data gathering, including local fieldwork teams.
- Findings from key industry events and interviews with leading market players and opinion leaders.
- Partnerships with leading research agencies.
- Quantitative and qualitative research and client collaborations.
- Cross-referenced data between markets.
- Tamarind Media proprietary market model.
Please note that each report has its own methodology, so you should always refer to the methodology applied in the report you purchase.
LOADING...
